Impact of Sickle Cell Disease on Academic Performance: A Cross Sectional Study

References

• Colombatti R, Casale M, Russo G. Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority. Ital J Pediatr. 2021;47(1). doi:10.1186/s13052-021-01109-1
   PubMed Web of Science ®Google Scholar
• Prussien KV, Siciliano RE, Ciriegio AE, et al. Correlates of cognitive function in sickle cell disease: a meta-analysis. J Pediatr Psychol. 2020;45(2):145–155. doi:10.1093/jpepsy/jsz100
   PubMed Web of Science ®Google Scholar
• Alsaeed ES, Farhat GN, Assiri AM, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2018;7(S1):S41–7. doi:10.1016/j.jegh.2017.12.001
   PubMedGoogle Scholar
• AlHamdan NAR, AlMazrou YY, AlSwaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372–377. doi:10.1097/GIM.0b013e318065a9e8
   PubMed Web of Science ®Google Scholar
• Zuair A, Bin AS, Alhumaidi R, Alrabiah M, Alshabanat A. The burden of sickle cell disease in Saudi Arabia: a single-institution large retrospective study. Int J Gen Med. 2023;16:161–171. doi:10.2147/IJGM.S393233
   PubMed Web of Science ®Google Scholar
• Almalky HA, Alwahbi AA. Teachers’ perceptions of their experience with inclusive education practices in Saudi Arabia. Res Dev Disabil. 2023;140:104584. doi:10.1016/j.ridd.2023.104584
   PubMed Web of Science ®Google Scholar
• McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol. 2011;18(3):158–165. doi:10.1097/MOH.0b013e32834521dd
   PubMed Web of Science ®Google Scholar
• Carden MA, Little J. Emerging disease-modifying therapies for sickle cell disease. In: Haematologica. Vol. 104. Ferrata Storti Foundation; 2019:1710–1719.
   Google Scholar
• Shah N, Bhor M, Xie L, Paulose J, Yuce H, Kamolz L-P. Sickle cell disease complications: prevalence and resource utilization. PLoS One. 2019;14(7):e0214355. doi:10.1371/journal.pone.0214355
   PubMed Web of Science ®Google Scholar
• El-Ghany SM A, Tabbakh AT, Nur KI, Abdelrahman RY, Etarji SM, Almuzaini BY. Analysis of causes of hospitalization among children with sickle cell disease in a group of private hospitals in jeddah, Saudi Arabia. J Blood Med. 2021;12:733–740. doi:10.2147/JBM.S318824
   PubMed Web of Science ®Google Scholar
• Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood. 2012;120(18):3647–3656. doi:10.1182/blood-2012-04-383430
   PubMed Web of Science ®Google Scholar
• Al-Saqladi AW. The impact of sickle cell disease severity on school performance in affected Yemeni children. J Appl Hematol. 2016;7(4):124. doi:10.4103/1658-5127.198506
   Google Scholar
• Schwartz LA, Radcliffe J, Barakat LP. Associates of school absenteeism in adolescents with sickle cell disease. Pediatr Blood Cancer. 2009;52(1):92–96. doi:10.1002/pbc.21819
   PubMed Web of Science ®Google Scholar
• Berkelhammer LD, Williamson AL, Sanford SD, et al. Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature. Child Neuropsychol. 2007;13(2):120–131. doi:10.1080/09297040600800956
   PubMed Web of Science ®Google Scholar
• Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289–293. doi:10.4103/0256-4947.81540
   PubMed Web of Science ®Google Scholar
• Alhazmi A, Hakami K, Abusageah F, et al. The impact of sickle cell disease on academic performance among affected students. Children. 2022;9(1):15.
   Google Scholar
• Rumaney MB, Ngo Bitoungui VJ, Vorster AA, et al. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One. 2014;9(6):e100516. doi:10.1371/journal.pone.0100516
   PubMed Web of Science ®Google Scholar
• Rabaah A, Doaa D, Asma A. Early childhood education in Saudi Arabia: report. World J Educ. 2016;6(5). doi:10.5430/wje.v6n5p1
   Google Scholar
• Hahn RA, Truman BI. Education improves public health and promotes health equity. Int J Health Serv. 2015;45(4):657–678. doi:10.1177/0020731415585986
   PubMed Web of Science ®Google Scholar
• Hu N, Fardell J, Wakefield CE, et al. School academic performance of children hospitalised with a chronic condition. Arch Dis Child. 2022;107(3):289–296. doi:10.1136/archdischild-2020-321285
   PubMed Web of Science ®Google Scholar
• Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127(3):750–760. doi:10.1172/JCI89741
   PubMed Web of Science ®Google Scholar
• Davis BA, Allard S, Qureshi A, et al. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol. 2017;176(2):192–209. doi:10.1111/bjh.14383
   PubMed Web of Science ®Google Scholar
• Alsalman M, Alkhalifa H, Alkhalifa A, et al. Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia. Health Sci Rep. 2021;4(4). doi:10.1002/hsr2.437
   Google Scholar
• Paikari A, Sheehan VA. Fetal haemoglobin induction in sickle cell disease. In: British Journal of Haematology. Vol. 180. Blackwell Publishing Ltd; 2018:189–200.
   Google Scholar
• Babeer G, Omran D, Bawahab N, et al. Prevalence and risk factors of stroke among children with sickle cell disease: a retrospective study at a tertiary care center. Cureus. 2023. doi:10.7759/cureus.41960
   PubMedGoogle Scholar
• Alsultan A, Alabdulaali MK, Griffin PJ, et al. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol. 2014;164(4):597–604. doi:10.1111/bjh.12650
   PubMed Web of Science ®Google Scholar